Sleep disorders in multiple sclerosis

Seminars in Neurology

Volumn 25, Issue 1, 2005, Pages 64-68

  Fleming, W Elon ^a   Pollak, Charles P ^b  

^a Island Hospital   (United States)

^b WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

Insomnia; Multiple sclerosis; Narcolepsy; Sleep disorders

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BACLOFEN; BENZODIAZEPINE DERIVATIVE; BETA1A INTERFERON; BOTULINUM TOXIN; CARBIDOPA; CHOLINERGIC RECEPTOR BLOCKING AGENT; CYCLOBENZAPRINE; DANTROLENE; DESMOPRESSIN; DIAZEPAM; DOPAMINE RECEPTOR STIMULATING AGENT; GABAPENTIN; GLATIRAMER; INTERFERON BETA SERINE; LEVODOPA; METHYLPREDNISOLONE SODIUM SUCCINATE; MITOXANTRONE; MODAFINIL; OPIATE; OXYBUTYNIN; PERGOLIDE; PRAMIPEXOLE; PROPANTHELINE BROMIDE; SEROTONIN UPTAKE INHIBITOR; TIZANIDINE; TRICYCLIC ANTIDEPRESSANT AGENT;

BLADDER DISEASE; DEPRESSION; DISEASE SEVERITY; DRUG EFFECT; FATIGUE; HUMAN; INSOMNIA; MOTOR DYSFUNCTION; MULTIPLE SCLEROSIS; NARCOLEPSY; NOCTURIA; PAIN; PARASOMNIA; PERIODIC LIMB MOVEMENT DISORDER; PRIORITY JOURNAL; PSYCHOTHERAPY; QUALITY OF LIFE; REVIEW; SLEEP DISORDER; SLEEP DISORDERED BREATHING; SOMNOLENCE; SPASTICITY;

HUMANS; MULTIPLE SCLEROSIS; NARCOLEPSY; SLEEP DISORDERS; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 16444367435     PISSN: 02718235     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-867075     Document Type: Review

References (51)

1. Tachibana N, Howard RS, Hirsch NP, Miller DH, Moseley IF, Fish D. Sleep problems in multiple sclerosis. Eur Neurol 1994;34:320-323
2. Saunders J, Whitham R, Schaumann B. Sleep disturbance, fatigue, and depression in multiple sclerosis. Neurology 1991;41(suppl 1):320
3. Leo GJ, Rao M, Bernardin L. Sleep disturbances in multiple sclerosis. Neurology 1991;41(suppl 1):320
4. Achiron A, Barak Y, Gabbay U. Sleep disturbance in multiple sclerosis: clinical and neuroradiologic correlations related to disease activity. J Neuroimmunol 1995;56-63(suppl 1):57
5. Ford DE, Kamerow DB. Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention? JAMA 1989;262:1479-1484
6. Sadovnick AD, Remick RA, Allen J, et al. Depression and multiple sclerosis. Neurology 1996;46:628-632
7. Feinstein A, Kartsounis LD, Miller DH, Youl BD, Ron MA. Clinically isolated lesions of the type seen in multiple sclerosis: a cognitive, psychiatric, and MRI follow up study. J Neurol Neurosurg Psychiatry 1992;55:869-876
8. Fruehwald S, Loeffler-Stastka H, Eher R, Saletu B, Baumhackl U. Depression and quality of life in multiple sclerosis. Acta Neurol Scand 2001;104:257-261
9. Rae-Grant AD, Eckert NJ, Bartz S, Reed JF. Sensory symptoms of multiple sclerosis: a hidden reservoir of morbidity. Mult Scler 1999;5:179-183
10. Ferini-Strambi L, Filippi M, Martinelli V, et al. Nocturnal sleep study in multiple sclerosis: correlations with clinical and brain magnetic resonance imaging findings. J Neurol Sci 1994;125:194-197
11. Coleman RM, Pollak CP, Weitzman ED. Periodic movements in sleep (nocturnal myoclonus): relation to sleep disorders. Ann Neurol 1980;8:416-421
12. Ekbom KA. Restless legs: a clinical study. Acta Med Scand Suppl 1945;158:1
13. Strang RR. The symptom of restless legs. Med J Aust 1967;1:1211-1213
14. Lavigne GJ, Montplaisir JY. Restless legs syndrome and sleep bruxism: prevalence and association among Canadians. Sleep 1994;17:739-743
15. Coleman RM, Bliwise DL, Sajben N, et al. Epidemiology of periodic limb movements during sleep. In: Guilleinault C, Lugaresi E, eds. Sleep/Wake Disorders: Natural History, Epidemiology and Long Term Evolution. New York: Raven Press; 1988:217-229
16. Montplaisir J, Boucher S, Poirier G, Lavigne G, Lapierre O, Lesperance P. Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria. Mov Disord 1997;12:61-65
17. Montplaisir J, Lapierre O, Warnes H, Pelletier G. The treatment of the restless leg syndrome with or without periodic leg movements in sleep. Sleep 1992;15:391-395
18. Lugaresi E, Cirignotta F, Coccagna G, Montagna P. Nocturnal myoclonus and restless legs syndrome. Adv Neurol 1986;43:295-307
19. Desautels A, Turecki G, Montplaisir J, Sequeira A, Verner A, Rouleau GA. Identification of a major susceptibility locus for restless legs syndrome on chromosome 12q. Am J Hum Genet 2001;69:1266-1270
20. Bonati MT, Ferini-Strambi L, Aridon P, Oldani A, Zucconi M, Casari G. Autosomal dominant restless legs syndrome maps on chromosome 14q. Brain 2003;126:1485-1492
21. Onen SH, Alloui A, Gross A, Eschallier A, Dubray C. The effects of total sleep deprivation, selective sleep interruption and sleep recovery on pain tolerance thresholds in healthy subjects. J Sleep Res 2001;10:35-42
22. Solaro C, Uccelli MM, Guglieri P, Uccelli A, Mancardi GL. Gabapentin is effective in treating nocturnal painful spasms in multiple sclerosis. Mult Scler 2000;6:192-193
23. Amarenco G, Kerdraon J, Denys P. [Bladder and sphincter disorders in multiple sclerosis. Clinical, urodynamic and neurophysiological study of 225 cases]. Rev Neurol (Paris) 1995;151:722-730
24. Leo GJ, Rao SM, Bernardin L. Sleep disturbance in multiple sclerosis. Neurology 1991;41(suppl 1):320 (Abstract)
25. Nuotio M, Tammela TL, Luukkaala T, Jylha M. Predictors of institutionalization in an older population during a 13-year period: the effect of urge incontinence. J Gerontol A Biol Sci Med Sci 2003;58:756-762
26. Valiquette G, Herbert J, Maede-D'Alisera P. Desmopressin in the management of nocturia in patients with multiple sclerosis. A double-blind, crossover trial. Arch Neurol 1996;53:1270-1275
27. Rebif®. Product information, 2002
28. Huber S, Spycher M, Lechner-Scott J, Bellaiche Y, Steck AJ, Kappos L. [Multiple sclerosis: Therapy with recombinant beta-1b interferon: initial results with 30 multiple sclerosis patients in northwest Switzerland]. Schweiz Med Wochenschr 1996;126:1475-1481
29. Antonijevic IA, Steiger A. Depression-like changes of the sleep-EEG during high dose corticosteroid treatment in patients with multiple sclerosis. Psychoneuroendocrinology 2003;28:780-795
30. Patten SB, Fridhandler S, Beck CA, Metz LM. Depressive symptoms in a treated multiple sclerosis cohort. Mult Scler 2003;9:616-620
31. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993;328:1230-1235
32. Auer RN, Rowlands CG, Perry SF, Remmers JE. Multiple sclerosis with medullary plaques and fatal sleep apnea (Ondine's curse). Clin Neuropathol 1996;15:101-105
33. Wunderlin BW, Kesselring J, Ginzler H, et al. Fatigue in multiple sclerosis is not due to sleep apnea. Eur J Neurol 1997;4:72-78
34. Howard RS, Wiles CM, Hirsch NP, Loh L, Spencer GT, Newsom-Davis J. Respiratory involvement in multiple sclerosis. Brain 1992;115:479-494
35. Schrader H, Gotlibsen OB, Skomedal GN. Multiple sclerosis and narcolepsy/cataplexy in a monozygotic twin. Neurology 1980;30:105-108
36. Bonduelle M, Degos C. Symptomatic narcolepsies: a critical study. In: Guilleminault C, Dement WC, Passouant P, eds. Narcolepsy. New York: Spectrum; 1976:322-325
37. Langdon N, Welsh KI, van Dam M, Vaughan RW, Parkes D. Genetic markers in narcolepsy. Lancet 1984;2:1178-1180
38. Caballero A, Alves-Leon S, Papais-Alvarenga R, Fernandez O, Navarro G, Alonso A. DQB1*0602 confers genetic susceptibility to multiple sclerosis in Afro-Brazilians. Tissue Antigens 1999;54:524-526
39. Mignot E, Lin X, Arrigoni J, et al. DQB1*0602 and DQA1*102 (DQ1) are better markers than DR2 for narcolepsy in Caucasian and black Americans. Sleep 1994;17(suppl 8):S60-S67
40. Juji T, Satake M, Honda Y, Doi Y. HLA antigens in Japanese patients with narcolepsy. All the patients were DR2 positive. Tissue Antigens 1984;24:316-319
41. Duquette P, Decary F, Pleines J, et al. Clinical sub-groups of multiple sclerosis in relation to HLA: DR alleles as possible markers of disease progression. Can J Neurol Sci 1985;12:106-110
42. Younger DS, Pedley TA, Thorpy MJ. Multiple sclerosis and narcolepsy: possible similar genetic susceptibility. Neurology 1991;41:447-448
43. Iseki K, Mezaki T, Oka Y, et al. Hypersomnia in MS. Neurology 2002;59:2006-2007
44. Billiard M, Besset A, Montplaisir J, et al. Modafinil: a double-blind multicentric study. Sleep 1994;17(suppl 8):S107-S112
45. Kato T, Kanbayashi T, Yamamoto K, et al. Hypersomnia and low CSF hypocretin-1 (orexin-A) concentration in a patient with multiple sclerosis showing bilateral hypothalamic lesions. Intern Med 2003;42:743-745
46. Rammohan KW, Rosenberg JH, Lynn DJ, Blumenfeld AM, Pollak CP, Nagaraja HN. Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study. J Neurol Neurosurg Psychiatry 2002;72:179-183
47. Scammell TE, Estabrooke IV, McCarthy MT, et al. Hypothalamic arousal regions are activated during modafinil-induced wakefulness. J Neurosci 2000;20:8620-8628
48. Tison F, Wenning GK, Quinn NP, Smith SJ. REM sleep behaviour disorder as the presenting symptom of multiple system atrophy. J Neurol Neurosurg Psychiatry 1995;58:379-380
49. Uchiyama M, Isse K, Tanaka K, et al. Incidental Lewy body disease in a patient with REM sleep behavior disorder. Neurology 1995;45:709-712
50. Wright BA, Rosen JR, Buysse DJ, Reynolds CF, Zubenko GS. Shy-Drager syndrome presenting as a REM behavioral disorder. J Geriatr Psychiatry Neurol 1990;3:110-113
51. Plazzi G, Montagna P. Remitting REM sleep behavior disorder as the initial sign of multiple sclerosis. Sleep Med 2002;3:437-439